RituBridge ELISA    For Rituxan Biosimilar Comparison

Complete kit for the systematic 3-D conformational comparability analysis of 

Rituxan biosimilar molecule to Rituximab (Rituxan trade name)

Rituximab is a chimeric monoclonal antibody that targets CD20, a cell-surface receptor on Bcells. 

It is used for the treatment of lymphomas, leukemia’s and autoimmune diseases that are 

characterized by an overabundance of B-cells. 

This kit will allow for conformational comparison between Rituxan Biosimilars and authentic Rituximab.   

☞   Click here for detailed product instruction

☞   Click here for RituBridge MSDS